Sort
40,608 grants matching “prostate cancer”
CYP17A1-independent androgen synthesis and prostate cancer resistance to next-generation hormonal therapy
$368,288Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
Determinants of prostate cancer sensitivity to PD-1 blockade
$368,288Lawrence Fong · University Of California, San Francisco · R01 · FY2021 · CA
Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer
$368,288Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Survival and Recurrence of Dormant Cancer Cells
$368,288Lewis A Chodosh · University Of Pennsylvania · R01 · FY2021 · CA
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$368,288Arnold I. Caplan · Case Western Reserve University · R01 · FY2020 · CA
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells
$368,288Zihua Gong · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapy
$368,281Justin J Wilson · Cornell University · R01 · FY2020 · EB
Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma
$368,280Dai H Chung · Vanderbilt University · R01 · FY2010 · DK
Control of Prostate-Specific Gene Expression
$368,280Robert J Matusik · Vanderbilt University · R01 · FY2010 · DK
A novel mitotic regulatory axis in neuroendocrine prostate cancer
$368,279Qiming Jane Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Heparan Sulfate Proteoglycans in Bone Stromal Metastasis
$368,255Mary C Farach-Carson · Cedars-Sinai Medical Center · P01 · FY2012 · CA
Impact of Direct to Consumer Genetic Testing
$368,231Robert C. Green · Brigham And Women'S Hospital · R01 · FY2011 · HG
Open source diffusion MRI technology for brain cancer research
$368,226Lauren Jean O'Donnell · Brigham And Women'S Hospital · U01 · FY2015 · CA
Targeting the MLL complex in Castration Resistant Prostate Cancer
$368,224Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
PROJECT 2: Understanding the role of TP53 in LMS development
$368,212David Thomas · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
Imaging T-cell Activation and Co-stimulation in Prostate Cancer Immunotherapy
$368,132Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Mechanisms of cancer cell chemotaxis in perineural invasion
$368,132Richard J Wong · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Statistical Strategies for Establishing Etiologic Heterogeneity of Tumors
$368,132Colin B Begg · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
$368,100Bertal H. Aktas · Brigham And Women'S Hospital · R01 · FY2012 · CA
Clinical Fellowship Training Program
$368,094Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2011 · CA
Microarray Platform for Profiling Cancer Proteases
$368,009Benjamin F Cravatt · Scripps Research Institute, The · R33 · FY2008 · CA
Pooling of Prospective Studies of Diet and Cancer
$367,986Stephanie A Smith-Warner · Harvard School Of Public Health · P01 · FY2007 · CA
Androgen Signaling in prostate cancer progression and CRPC development
$367,955Zijie Sun · Stanford University · R01 · FY2014 · CA
Trk Expression and Inhibition in Human Neuroblastomas
$367,942Garrett M Brodeur · Children'S Hosp Of Philadelphia · R01 · FY2008 · CA
Multiparametric Photoacoustic Imaging-Based Identification of Aggressive Prostate Cancer
$367,933Haichong Zhang · Worcester Polytechnic Institute · DP5 · FY2023 · OD